Magellan Health, Inc. MGLN
Day range unavailable
52-week range unavailable
- Market cap
- 2.50B
- Revenue (ttm)
- 4.82B
- Profit margin
- 6.26%
- Shares out
- 26.33M
- Forward P/E
- 27.86
- Beta
- 1.04
- Analysts
- Hold
- Price target
- 95.00 (+0.0%)
- Earnings date
- Feb 25, 2022
Key statistics
- Enterprise value
- 2.09B
- PEG ratio
- -39.71
- Price / sales
- 0.52
- Price / book
- 1.29
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 7.20%
- Free cash flow
- 689.85M
- Total cash
- 1.01B
- Total debt
- 562.64M
- Return on equity
- -0.16%
- Short % of float
- 5.71%
- 50-day average
- 94.68
- 200-day average
- 94.47
Analyst view
Consensus: hold
- Strong buy1
- Buy1
- Hold2
- Sell0
- Strong sell0
Next earnings
Feb 25, 2022
Expected Feb 25, 2022. Consensus EPS estimate 0.38.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 25, 2022 | Dec 1, 2021 | 0.42 | — | — | — |
| Nov 5, 2021 | Sep 1, 2021 | 0.00 | — | — | — |
| Aug 5, 2021 | Jun 1, 2021 | 0.00 | — | — | — |
| Apr 30, 2021 | Mar 1, 2021 | 0.78 | — | — | — |
| Feb 26, 2021 | Dec 1, 2020 | -0.30 | — | — | — |
| Oct 29, 2020 | Sep 1, 2020 | -0.12 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 15, 2021 | Jefferies | down | Buy | Hold |
| Jan 6, 2021 | Stephens & Co. | down | Overweight | Equal-Weight |
| Sep 10, 2020 | B of A Securities | main | — | Buy |
| Jul 30, 2020 | Jefferies | main | — | Buy |
| Feb 22, 2019 | Bank of America | init | — | Buy |
| Jan 14, 2019 | Stephens & Co. | init | — | Equal-Weight |
About Magellan Health, Inc.
Magellan Health, Inc., together with its subsidiaries, provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans; and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Further, it offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions. In addition, the company provides services to health plans and managed care organizations, employers, labor unions, third party administrators, state governments, military and governmental agencies, exchanges, brokers, and consultants. Magellan Health, Inc. was incorporated in 1969 and is headquartered in Phoenix, Arizona. As of January 4, 2022, Magellan Health, Inc. operates as a subsidiary of Centene Corporation.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Country
- United States
- Website
- magellanhealth.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on MGLN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ABBOTT SWATI BARGOTRA | Director | Stock Award(Grant) | Aug 12, 2021 | 6,847 |
| CHEN CHRISTOPHER J | Director | Stock Award(Grant) | Aug 12, 2021 | 2,911 |
| FELD PETER A. | Director | Stock Award(Grant) | Aug 12, 2021 | 2,374,800 |
| JOSEPHSON MURAL R | Director | Stock Award(Grant) | Aug 12, 2021 | 2,911 |
| MACKENZIE GREGORY SCOTT | Director | Stock Award(Grant) | Aug 12, 2021 | 10,594 |
| MURRAY JAMES E | President | Conversion of Exercise of derivative security | Mar 3, 2021 | 10,812 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 14.28% | 3,760,608 | 355.57M | Sep 29, 2021 |
| Vanguard Group, Inc. (The) | 9.29% | 2,447,193 | 231.38M | Sep 29, 2021 |
| Starboard Value LP | 9.00% | 2,369,100 | 224.00M | Sep 29, 2021 |
| Dimensional Fund Advisors LP | 5.42% | 1,427,148 | 134.94M | Sep 29, 2021 |
| Healthcare of Ontario Pension Plan Trust Fund | 5.01% | 1,318,400 | 124.65M | Sep 29, 2021 |
| Magnetar Financial LLC | 4.62% | 1,215,822 | 114.96M | Sep 29, 2021 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Core S&P Smallcap ETF | 5.93% | 1,562,562 | 148.18M | Oct 30, 2021 |
| Vanguard Total Stock Market Index Fund | 2.54% | 669,940 | 63.34M | Sep 29, 2021 |
| Vanguard Small-Cap Index Fund | 2.25% | 591,621 | 55.94M | Sep 29, 2021 |
| iShares Russell 2000 ETF | 2.09% | 551,259 | 52.28M | Oct 30, 2021 |
| DFA U.S. Small Cap Value Series | 1.85% | 487,257 | 46.21M | Oct 30, 2021 |
| Highland Fds I-NexPoint Merger Arbitrage Fund | 1.76% | 464,306 | 43.90M | Sep 29, 2021 |
